NCT02039557
Completed
Not Applicable
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Patients Transplanted With NiCord/CordIn (Omidubicel)
- Sponsor
- Gamida Cell ltd
- Enrollment
- 33
- Locations
- 9
- Primary Endpoint
- long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation
Time Frame: 5 years
Study Sites (9)
Loading locations...
Similar Trials
Enrolling By Invitation
Not Applicable
A Long Term Follow-Up Study for Subjects Who Have Received Q-CellsTransverse MyelitisNCT06163508University of Texas Southwestern Medical Center9
Terminated
Not Applicable
Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging AgentCoronary Artery DiseaseNCT00584714Point Biomedical300
Terminated
Not Applicable
An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMRKidney Transplant RejectionNCT04711850Hansa Biopharma AB18
Unknown
Not Applicable
Safety and Efficacy Study of Spinal TetheringAdolescent Idiopathic ScoliosisNCT02897453Zimmer Biomet56
Active, not recruiting
Phase 3
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)2024-512580-31-00Sangamo Therapeutics Inc.20